Featured Story
Alzheimer’s Disease: A Smoking Gun with No Suspect
For the past 30 years, there has been one assumed culprit of Alzheimer’s disease (AD) — beta-amyloid. However, researchers have been unsuccessful in developing effective therapies targeting this protein. Understand the history of AD and beta-amyloid and see what other biomarkers are being investigated as potential therapeutic targets.
Newest Articles
Six Tips to Improve Your Co-IP Results
Co-immunoprecipitation (co-IP) is a great way to identify target protein complexes and interacting partners. Though the technique can be highly informative, it is also challenging to master. The six tips and protocol outlined in this article will help you achieve successful co-IP results.
Single-Step Influenza and Dengue Virus Purification with Mixed-Mode CHT Ceramic Hydroxyapatite XT Media
See how you can use CHT XT Mixed-Mode Media to recover over 75% of your virus in a single purification step. All this while reducing contaminating proteins by over 90% and removing over 60% of dsDNA. Get simple, fast, and reproducible viral purification with CHT XT.
Bio-Plex Manager Software Overview
Presented by: Brett Houser, Bio-Plex Multiplex Immunoassay Product Manager, Protein Quantitation Group
Date: Wednesday, October 17, 2018
Time: 11 AM, U.S. Pacific time
Bio-Plex Manager Software is a powerful, intuitive tool used to generate and analyze xMap data. In this webinar you will:
- Learn how to create an assay protocol
- Learn how to acquire data
- Understand basic software parameters
- Learn about general functionality and navigation
- Master optimization of standard curves and export data for further analysis
A 16-Color Flow Cytometry Panel to Monitor Checkpoint Inhibitor Expression and T-Cell Exhaustion Following Treatment with the PD1 Inhibitor Nivolumab
Presented by: Angie Green, PhD, Senior Scientist
Date: Tuesday, November 6, 2018
Time: 8 AM and 4 PM U.S. Pacific time
4 PM Greenwich mean time
8 AM Singapore time (November 7)
We discuss using a multiparameter flow cytometry panel to monitor T-cell exhaustion states and the expression of checkpoint inhibitors. We used an in vitro model; however, the panel is designed to be compatible with clinical samples to monitor immunotherapy.